Recruiting
Phase 3

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Sponsor:

VA Office of Research and Development

Code:

NCT05931276

Conditions

End-Stage Kidney Disease

End-Stage Renal Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Metoprolol Succinate

Carvedilol

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information